- Home
- DTST vs DARE Comparison
DTST vs DARE Comparison
Compare DTST & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- DARE
- Stock Information
- Founded
- DTST 2001
- DARE 2015
- Country
- DTST United States
- DARE United States
- Employees
- DTST N/A
- DARE N/A
- Industry
- DTST EDP Services
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- DARE Health Care
- Exchange
- DTST Nasdaq
- DARE Nasdaq
- Market Cap
- DTST 28.2M
- DARE 26.3M
- IPO Year
- DTST N/A
- DARE N/A
- Fundamental
- Price
- DTST $3.53
- DARE $2.52
- Analyst Decision
- DTST
- DARE Strong Buy
- Analyst Count
- DTST 0
- DARE 3
- Target Price
- DTST N/A
- DARE $12.50
- AVG Volume (30 Days)
- DTST 29.6K
- DARE 443.5K
- Earning Date
- DTST 08-13-2025
- DARE 08-11-2025
- Dividend Yield
- DTST N/A
- DARE N/A
- EPS Growth
- DTST N/A
- DARE N/A
- EPS
- DTST 0.02
- DARE N/A
- Revenue
- DTST $25,219,312.00
- DARE $25,909.00
- Revenue This Year
- DTST $12.57
- DARE $99,756.91
- Revenue Next Year
- DTST $9.29
- DARE $119.77
- P/E Ratio
- DTST $149.84
- DARE N/A
- Revenue Growth
- DTST N/A
- DARE N/A
- 52 Week Low
- DTST $2.93
- DARE $2.11
- 52 Week High
- DTST $6.53
- DARE $4.60
- Technical
- Relative Strength Index (RSI)
- DTST 49.28
- DARE 41.75
- Support Level
- DTST $3.33
- DARE $2.37
- Resistance Level
- DTST $3.56
- DARE $2.54
- Average True Range (ATR)
- DTST 0.13
- DARE 0.14
- MACD
- DTST 0.02
- DARE -0.00
- Stochastic Oscillator
- DTST 70.00
- DARE 59.56
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.